ASND Ascendis Pharma A/S
Healthcare$239.65-3.00%ClosedMarket Cap: $14.81B
As of 2026-05-26
Institutional Ownership Summary
Investors Holding
327
13F Shares
64,677,003
Ownership %
106.0%
New Positions
57
Increased Positions
181
Closed Positions
42
Reduced Positions
96
ETF Exposure
| ETF Symbol | ETF Name | Shares Held | Weight % |
|---|---|---|---|
| American Century Focused Dynamic Growth ETF | 49,388 | 2.87% | |
| 254,766 | 2.84% | ||
| 49,756 | 2.80% | ||
| T. Rowe Price Capital Appreciation Equity ETF | 333,325 | 1.19% | |
| iShares Biotechnology ETF | 339,948 | 0.95% | |
| Invesco NASDAQ Next Gen 100 ETF | 27,629 | 0.74% | |
| 1,103,469 | 0.59% | ||
| 1,103,469 | 0.59% | ||
| American Century Ultra Investor Class | 664,000 | 0.53% | |
| 46,000 | 0.26% | ||
| 214,582 | 0.22% | ||
| 214,582 | 0.22% | ||
| 14,298 | 0.20% | ||
| T. Rowe Price Small-Mid Cap ETF | 11,627 | 0.17% | |
| Fidelity Nasdaq Composite Index ETF | 14,308 | 0.04% | |
| State Street SPDR Portfolio Developed World ex-US ETF | 60,527 | 0.04% | |
| First Trust Innovation Leaders ETF | 13,998 | 0.00% |